From GlobeNewswire:

Acumen Pharmaceuticals, Inc. is set to present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024. The event will take place in San Francisco at 10:30 a.m. PT (1:30 p.m. ET). The live webcast can be accessed on the company’s website and will be available for 90 days. Acumen is a clinical-stage biopharmaceutical company developing a therapeutic for Alzheimer’s disease, with promising Phase 1 trial results. For more information, visit Acumen Pharmaceuticals, Inc.’s website or contact media and investor relations.



Read more: Acumen Pharmaceuticals to Present at the 42nd Annual J.P.